Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to -$24000.0.

  • Niagen Bioscience's Cash from Investing Activities fell 1428.57% to -$24000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$260000.0, marking a year-over-year decrease of 17368.42%. This contributed to the annual value of -$143000.0 for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Niagen Bioscience's Cash from Investing Activities stood at -$24000.0, which was down 1428.57% from -$135000.0 recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Cash from Investing Activities registered a high of -$2000.0 during Q4 2021, and its lowest value of -$265000.0 during Q2 2021.
  • Its 5-year average for Cash from Investing Activities is -$64210.5, with a median of -$41000.0 in 2024.
  • Per our database at Business Quant, Niagen Bioscience's Cash from Investing Activities crashed by 850000.0% in 2022 and then skyrocketed by 9411.76% in 2023.
  • Quarter analysis of 5 years shows Niagen Bioscience's Cash from Investing Activities stood at -$2000.0 in 2021, then crashed by 8500.0% to -$172000.0 in 2022, then soared by 87.79% to -$21000.0 in 2023, then plummeted by 228.57% to -$69000.0 in 2024, then soared by 65.22% to -$24000.0 in 2025.
  • Its last three reported values are -$24000.0 in Q3 2025, -$135000.0 for Q2 2025, and -$32000.0 during Q1 2025.